In silico preliminary evaluation of bioactive compounds from five Unani drugs as potential SARS-CoV-2 inhibitors: IN SILICO EVIDENCE OF FIVE UNANI DRUGS AGAINST SARS-COV-2. IJTK. 2024;23(3):247-261. doi:10.56042/ijtk.v23i3.1412